chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenopathy, Vaccination site inflammation, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: injection site swelled; very inflamed; hot to touch; very itchy; lymph nodes in armpit area swelled and were sore and icky; lymph nodes in armpit area swelled and were sore and icky; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (injection site swelled), VACCINATION SITE INFLAMMATION (very inflamed), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE PRURITUS (very itchy) and LYMPHADENOPATHY (lymph nodes in armpit area swelled and were sore and icky) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced VACCINATION SITE SWELLING (injection site swelled), VACCINATION SITE INFLAMMATION (very inflamed), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE PRURITUS (very itchy), LYMPHADENOPATHY (lymph nodes in armpit area swelled and were sore and icky) and AXILLARY PAIN (lymph nodes in armpit area swelled and were sore and icky). At the time of the report, VACCINATION SITE SWELLING (injection site swelled), VACCINATION SITE INFLAMMATION (very inflamed), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE PRURITUS (very itchy), LYMPHADENOPATHY (lymph nodes in armpit area swelled and were sore and icky) and AXILLARY PAIN (lymph nodes in armpit area swelled and were sore and icky) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided. Upon in internal review on  21 -May 2021, the age was corrected to  unknown  years"   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 20-Jan-2021: Upon internal review on 27 May 2021, it was discovered that the patient age was incorrectly captured as 121 years and DOB mentioned in source document was 01-Jan-1900, which was a MI error. The patient age and narrative has been updated to unknown age with reports re-submission and significant amendment is performed for the correction.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: injection site swelled; very inflamed; hot to touch; very itchy; lymph nodes in armpit area swelled and were sore and icky; lymph nodes in armpit area swelled and were sore and icky; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (injection site swelled), VACCINATION SITE INFLAMMATION (very inflamed), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE PRURITUS (very itchy) and LYMPHADENOPATHY (lymph nodes in armpit area swelled and were sore and icky) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced VACCINATION SITE SWELLING (injection site swelled), VACCINATION SITE INFLAMMATION (very inflamed), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE PRURITUS (very itchy), LYMPHADENOPATHY (lymph nodes in armpit area swelled and were sore and icky) and AXILLARY PAIN (lymph nodes in armpit area swelled and were sore and icky). At the time of the report, VACCINATION SITE SWELLING (injection site swelled), VACCINATION SITE INFLAMMATION (very inflamed), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE PRURITUS (very itchy), LYMPHADENOPATHY (lymph nodes in armpit area swelled and were sore and icky) and AXILLARY PAIN (lymph nodes in armpit area swelled and were sore and icky) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided. Upon in internal review on  21 -May 2021, the age was corrected to  unknown  years"   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 20-Jan-2021: Upon internal review on 27 May 2021, it was discovered that the patient age was incorrectly captured as 121 years and DOB mentioned in source document was 01-Jan-1900, which was a MI error. The patient age and narrative has been updated to unknown age with reports re-submission and significant amendment is performed for the correction.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test, Ultrasound abdomen
Clinical narrative: Maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (1 drink) on 11-Sep-2020. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from 27-Sep-2020 to an unknown date and FISH OIL (OMEGA 3 [FISH OIL]) from 27-Sep-2020 to an unknown date for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 15-Aug-2020 and the estimated date of delivery was 22-May-2021. On 02-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-fourth week of the pregnancy.  On 02-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Sep-2020, Pregnancy test: positive (Positive) positive. On 27-Jan-2021, Ultrasound abdomen: normal (normal) no anomalies.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment Medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination complication, Vaccination site erythema, Vaccination site induration, Vaccination site pruritus
Clinical narrative: headache; not feeling well; arm swelled up; arm was red; hardness formed; felt warm; arm started itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (arm started itching), VACCINATION SITE ERYTHEMA (arm was red), VACCINATION SITE INDURATION (hardness formed), VACCINATION SITE WARMTH (felt warm) and HEADACHE (headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included RABEPRAZOLE, RALOXIFENE, HYDROCODONE BITARTRATE, PARACETAMOL (HYDROCODONE/APAP), BIOTIN, CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), CALCIUM, DOCUSATE SODIUM (STOOL SOFTENER) and APIXABAN (ELIQUIS) for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (arm started itching). On 16-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (arm was red), VACCINATION SITE INDURATION (hardness formed), VACCINATION SITE WARMTH (felt warm) and VACCINATION SITE SWELLING (arm swelled up). On 21-Jan-2021, the patient experienced HEADACHE (headache) and VACCINATION COMPLICATION (not feeling well). At the time of the report, VACCINATION SITE PRURITUS (arm started itching), VACCINATION SITE ERYTHEMA (arm was red), VACCINATION SITE INDURATION (hardness formed), VACCINATION SITE WARMTH (felt warm), HEADACHE (headache), VACCINATION COMPLICATION (not feeling well) and VACCINATION SITE SWELLING (arm swelled up) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: headache; not feeling well; arm swelled up; arm was red; hardness formed; felt warm; arm started itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (arm started itching), VACCINATION SITE ERYTHEMA (arm was red), VACCINATION SITE INDURATION (hardness formed), VACCINATION SITE WARMTH (felt warm) and HEADACHE (headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included RABEPRAZOLE, RALOXIFENE, HYDROCODONE BITARTRATE, PARACETAMOL (HYDROCODONE/APAP), BIOTIN, CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), CALCIUM, DOCUSATE SODIUM (STOOL SOFTENER) and APIXABAN (ELIQUIS) for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (arm started itching). On 16-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (arm was red), VACCINATION SITE INDURATION (hardness formed), VACCINATION SITE WARMTH (felt warm) and VACCINATION SITE SWELLING (arm swelled up). On 21-Jan-2021, the patient experienced HEADACHE (headache) and VACCINATION COMPLICATION (not feeling well). At the time of the report, VACCINATION SITE PRURITUS (arm started itching), VACCINATION SITE ERYTHEMA (arm was red), VACCINATION SITE INDURATION (hardness formed), VACCINATION SITE WARMTH (felt warm), HEADACHE (headache), VACCINATION COMPLICATION (not feeling well) and VACCINATION SITE SWELLING (arm swelled up) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site urticaria, Pruritus, Rash, Urticaria
Clinical narrative: a rash above and below the injection site with hives on the arm of the injection site; arm itchy; hives on her shoulder above and below the injection site; red; sore arm/pain in the left site; rash in her hand; a rash above and below the injection site with hives on the arm of the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (a rash above and below the injection site with hives on the arm of the injection site), INJECTION SITE URTICARIA (a rash above and below the injection site with hives on the arm of the injection site), PRURITUS (arm itchy), URTICARIA (hives on her shoulder above and below the injection site) and ERYTHEMA (red) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CALCIUM and VITAMINS NOS for an unknown indication.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE RASH (a rash above and below the injection site with hives on the arm of the injection site). On an unknown date, the patient experienced INJECTION SITE URTICARIA (a rash above and below the injection site with hives on the arm of the injection site), PRURITUS (arm itchy), URTICARIA (hives on her shoulder above and below the injection site), ERYTHEMA (red), VACCINATION SITE PAIN (sore arm/pain in the left site) and RASH (rash in her hand). At the time of the report, VACCINATION SITE RASH (a rash above and below the injection site with hives on the arm of the injection site) and INJECTION SITE URTICARIA (a rash above and below the injection site with hives on the arm of the injection site) outcome was unknown and PRURITUS (arm itchy), URTICARIA (hives on her shoulder above and below the injection site), ERYTHEMA (red), VACCINATION SITE PAIN (sore arm/pain in the left site) and RASH (rash in her hand) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included Benadryl and cortisone cream.  Concomitant medication included thyroid pills.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jan-2021: Route of administration, patient details, treatment information and events updated.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash
Clinical narrative: a rash above and below the injection site with hives on the arm of the injection site; arm itchy; hives on her shoulder above and below the injection site; red; sore arm/pain in the left site; rash in her hand; a rash above and below the injection site with hives on the arm of the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (a rash above and below the injection site with hives on the arm of the injection site), INJECTION SITE URTICARIA (a rash above and below the injection site with hives on the arm of the injection site), PRURITUS (arm itchy), URTICARIA (hives on her shoulder above and below the injection site) and ERYTHEMA (red) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CALCIUM and VITAMINS NOS for an unknown indication.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE RASH (a rash above and below the injection site with hives on the arm of the injection site). On an unknown date, the patient experienced INJECTION SITE URTICARIA (a rash above and below the injection site with hives on the arm of the injection site), PRURITUS (arm itchy), URTICARIA (hives on her shoulder above and below the injection site), ERYTHEMA (red), VACCINATION SITE PAIN (sore arm/pain in the left site) and RASH (rash in her hand). At the time of the report, VACCINATION SITE RASH (a rash above and below the injection site with hives on the arm of the injection site) and INJECTION SITE URTICARIA (a rash above and below the injection site with hives on the arm of the injection site) outcome was unknown and PRURITUS (arm itchy), URTICARIA (hives on her shoulder above and below the injection site), ERYTHEMA (red), VACCINATION SITE PAIN (sore arm/pain in the left site) and RASH (rash in her hand) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included Benadryl and cortisone cream.  Concomitant medication included thyroid pills.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jan-2021: Route of administration, patient details, treatment information and events updated.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Blood glucose increased, Chills, Fatigue, Vaccination site swelling
Clinical narrative: glucose levels have gone up every day; swelling at the site of injection; fatigue; chills; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of BLOOD GLUCOSE INCREASED (glucose levels have gone up every day), VACCINATION SITE SWELLING (swelling at the site of injection), FATIGUE (fatigue) and CHILLS (chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE SWELLING (swelling at the site of injection), FATIGUE (fatigue) and CHILLS (chills). On 19-Jan-2021, the patient experienced BLOOD GLUCOSE INCREASED (glucose levels have gone up every day). At the time of the report, BLOOD GLUCOSE INCREASED (glucose levels have gone up every day), VACCINATION SITE SWELLING (swelling at the site of injection), FATIGUE (fatigue) and CHILLS (chills) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Jan-2021, Blood glucose: 169. On 20-Jan-2021, Blood glucose: 183. On 21-Jan-2021, Blood glucose: 210.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient takes oral medications for diabetes. No treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm is sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm is sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm is sore). At the time of the report, PAIN IN EXTREMITY (arm is sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported No treatment medications were reported
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Headache, Pyrexia
Clinical narrative: Weakness; headache; little fever; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), HEADACHE (headache) and PYREXIA (little fever) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced ASTHENIA (Weakness), HEADACHE (headache) and PYREXIA (little fever). At the time of the report, ASTHENIA (Weakness), HEADACHE (headache) and PYREXIA (little fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported Patient took aspirin to treat symptoms
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Headache; Fever with chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever with chills) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021 at 7:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PYREXIA (Fever with chills). On 21-Jan-2021, the patient experienced HEADACHE (Headache). At the time of the report, PYREXIA (Fever with chills) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported Patient took acetaminophen for treatment
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: itchiness on the injection site; rash on the injection site; swelling on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchiness on the injection site), VACCINATION SITE RASH (rash on the injection site) and VACCINATION SITE SWELLING (swelling on the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itchiness on the injection site), VACCINATION SITE RASH (rash on the injection site) and VACCINATION SITE SWELLING (swelling on the injection site). At the time of the report, VACCINATION SITE PRURITUS (itchiness on the injection site), VACCINATION SITE RASH (rash on the injection site) and VACCINATION SITE SWELLING (swelling on the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported No treatment medications were reported
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Headache, Limb discomfort, Lymphadenopathy, Myalgia
Clinical narrative: muscle pain; leg muscles; biceps; strange pain in the back of the head; huge lymph nodes at the back of head, clavicle; severe tenderness; back; migrating throughout arms; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (severe tenderness), BACK PAIN (back), LIMB DISCOMFORT (migrating throughout arms), MYALGIA (muscle pain; leg muscles; biceps) and HEADACHE (strange pain in the back of the head) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced TENDERNESS (severe tenderness), BACK PAIN (back), LIMB DISCOMFORT (migrating throughout arms), HEADACHE (strange pain in the back of the head) and LYMPHADENOPATHY (huge lymph nodes at the back of head, clavicle). On an unknown date, the patient experienced MYALGIA (muscle pain; leg muscles; biceps). At the time of the report, TENDERNESS (severe tenderness), BACK PAIN (back), LIMB DISCOMFORT (migrating throughout arms), MYALGIA (muscle pain; leg muscles; biceps), HEADACHE (strange pain in the back of the head) and LYMPHADENOPATHY (huge lymph nodes at the back of head, clavicle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: muscle pain; leg muscles; biceps; strange pain in the back of the head; huge lymph nodes at the back of head, clavicle; severe tenderness; back; migrating throughout arms; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (severe tenderness), BACK PAIN (back), LIMB DISCOMFORT (migrating throughout arms), MYALGIA (muscle pain; leg muscles; biceps) and HEADACHE (strange pain in the back of the head) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced TENDERNESS (severe tenderness), BACK PAIN (back), LIMB DISCOMFORT (migrating throughout arms), HEADACHE (strange pain in the back of the head) and LYMPHADENOPATHY (huge lymph nodes at the back of head, clavicle). On an unknown date, the patient experienced MYALGIA (muscle pain; leg muscles; biceps). At the time of the report, TENDERNESS (severe tenderness), BACK PAIN (back), LIMB DISCOMFORT (migrating throughout arms), MYALGIA (muscle pain; leg muscles; biceps), HEADACHE (strange pain in the back of the head) and LYMPHADENOPATHY (huge lymph nodes at the back of head, clavicle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Influenza like illness, Pyrexia
Clinical narrative: flu like symptoms; temperature 99.1-100.4F; really bad headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (temperature 99.1-100.4 F), HEADACHE (really bad headache) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (temperature 99.1-100.4F), HEADACHE (really bad headache) and CHILLS (chills). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (temperature 99.1-100.4F), HEADACHE (really bad headache) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jan-2021, Body temperature: 99.1 degree Fahrenheit., she took Tylenol and then her temperature was 100.4 degree Fahrenheit..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported Patient took acetaminophen for her symptoms.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: positive for covid; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of COVID-19 (positive for covid) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (positive for covid). At the time of the report, COVID-19 (positive for covid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.    No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, COVID-19, Cough, Myalgia, Pyrexia
Clinical narrative: covid-19; Myalgia; Fever; cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), COVID-19 (covid-19), MYALGIA (Myalgia) and PYREXIA (Fever) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Unipolar depression. Concomitant products included LITHIUM CARBONATE for Unipolar depression, CLONAZEPAM for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced COUGH (cough), MYALGIA (Myalgia) and PYREXIA (Fever). On 17-Jan-2021, the patient experienced COVID-19 (covid-19). On 20-Jan-2021, PYREXIA (Fever) had resolved. At the time of the report, COUGH (cough), COVID-19 (covid-19) and MYALGIA (Myalgia) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Body temperature: 100.7 up to 100.7 degree Farenheit. On 17-Jan-2021, COVID-19: (Positive) going to be administered with monoclonal antibody infusion to treat his covid.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient also uses medications to treat his blood pressure. he mentioned he was going to be administered with monoclonal antibody infusion to treat his covid. on 22Jan2021 He took ibuprofen to treat his symptoms from 15Jan2021 to 21Jan2021.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested positive for covid a week later; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for covid a week later) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive for covid a week later). At the time of the report, COVID-19 (Tested positive for covid a week later) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test positive: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: a very sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (a very sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE PAIN (a very sore arm). At the time of the report, VACCINATION SITE PAIN (a very sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were not reported. Treatment information was not provided.    This case was linked to MOD-2021-011083 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: excruciating pain in his hips, lasted about 8 minutes, then wore off; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (excruciating pain in his hips, lasted about 8 minutes, then wore off) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (excruciating pain in his hips, lasted about 8 minutes, then wore off). At the time of the report, ARTHRALGIA (excruciating pain in his hips, lasted about 8 minutes, then wore off) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported No treatment medications were reported
Sex: U
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: body aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches) and PYREXIA (fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (body aches) and PYREXIA (fever). At the time of the report, PAIN (body aches) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Muscle spasms
Clinical narrative: lower extremities cramping that lasted 5-10mins; elevated blood pressure; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (lower extremities cramping that lasted 5-10mins) and BLOOD PRESSURE INCREASED (elevated blood pressure) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced MUSCLE SPASMS (lower extremities cramping that lasted 5-10mins) and BLOOD PRESSURE INCREASED (elevated blood pressure). On 20-Jan-2021, MUSCLE SPASMS (lower extremities cramping that lasted 5-10mins) had resolved. At the time of the report, BLOOD PRESSURE INCREASED (elevated blood pressure) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported.    No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Pain, Pyrexia
Clinical narrative: Mental cloudiness; Moderate body aches; Persistent headache; Low grade fever (99-100F); Chills; Significant pain/discomfortant at the injection site; Slight pain/discomfort at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Mental cloudiness), PAIN (Moderate body aches), HEADACHE (Persistent headache), PYREXIA (Low grade fever (99-100F)) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Dec-2020, the patient experienced VACCINATION SITE PAIN (Slight pain/discomfort at the injection site). On 19-Jan-2021, the patient experienced FEELING ABNORMAL (Mental cloudiness), PAIN (Moderate body aches), HEADACHE (Persistent headache), PYREXIA (Low grade fever (99-100F)), CHILLS (Chills) and VACCINATION SITE PAIN (Significant pain/discomfortant at the injection site). On 25-Dec-2020, VACCINATION SITE PAIN (Slight pain/discomfort at the injection site) had resolved. On 21-Jan-2021, FEELING ABNORMAL (Mental cloudiness), PAIN (Moderate body aches), HEADACHE (Persistent headache), PYREXIA (Low grade fever (99-100F)), CHILLS (Chills) and VACCINATION SITE PAIN (Significant pain/discomfortant at the injection site) had resolved.            Concomitant product use was not provided. Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Mental cloudiness; Moderate body aches; Persistent headache; Low grade fever (99-100F); Chills; Significant pain/discomfortant at the injection site; Slight pain/discomfort at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Mental cloudiness), PAIN (Moderate body aches), HEADACHE (Persistent headache), PYREXIA (Low grade fever (99-100F)) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Dec-2020, the patient experienced VACCINATION SITE PAIN (Slight pain/discomfort at the injection site). On 19-Jan-2021, the patient experienced FEELING ABNORMAL (Mental cloudiness), PAIN (Moderate body aches), HEADACHE (Persistent headache), PYREXIA (Low grade fever (99-100F)), CHILLS (Chills) and VACCINATION SITE PAIN (Significant pain/discomfortant at the injection site). On 25-Dec-2020, VACCINATION SITE PAIN (Slight pain/discomfort at the injection site) had resolved. On 21-Jan-2021, FEELING ABNORMAL (Mental cloudiness), PAIN (Moderate body aches), HEADACHE (Persistent headache), PYREXIA (Low grade fever (99-100F)), CHILLS (Chills) and VACCINATION SITE PAIN (Significant pain/discomfortant at the injection site) had resolved.            Concomitant product use was not provided. Treatment information was not provided.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Rash
Clinical narrative: Rash in the arm; Headaches; Pain in the arm; This spontaneous case was reported by a non-health professional and describes the occurrence of PAIN IN EXTREMITY (Pain in the arm), RASH (Rash in the arm) and HEADACHE (Headaches) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain in the arm) and HEADACHE (Headaches). On 21-Jan-2021, the patient experienced RASH (Rash in the arm). On 12-Jan-2021, PAIN IN EXTREMITY (Pain in the arm) and HEADACHE (Headaches) had resolved. At the time of the report, RASH (Rash in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, SARS-CoV-2 test positive
Clinical narrative: Tested positive for Covid-19; feeling bad; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for Covid-19) and FEELING ABNORMAL (feeling bad) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced FEELING ABNORMAL (feeling bad). On 18-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for Covid-19). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for Covid-19) and FEELING ABNORMAL (feeling bad) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported No treatment medications were reported
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Erythema, Fatigue, Feeling of body temperature change, Malaise
Clinical narrative: started feeling very ill/very sick; could not eat anything and was only able to swallow water; freezing alternating with feeling very hot; most of my arm was red and painful to touch; most of my arm was red and painful to touch; Nausea; body ache; very tired; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (started feeling very ill/very sick), DYSPHAGIA (could not eat anything and was only able to swallow water), FEELING OF BODY TEMPERATURE CHANGE (freezing alternating with feeling very hot), PAIN IN EXTREMITY (most of my arm was red and painful to touch) and ERYTHEMA (most of my arm was red and painful to touch) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced MALAISE (started feeling very ill/very sick), DYSPHAGIA (could not eat anything and was only able to swallow water), FEELING OF BODY TEMPERATURE CHANGE (freezing alternating with feeling very hot), PAIN IN EXTREMITY (most of my arm was red and painful to touch), ERYTHEMA (most of my arm was red and painful to touch), NAUSEA (Nausea), MYALGIA (body ache) and FATIGUE (very tired). At the time of the report, MALAISE (started feeling very ill/very sick), NAUSEA (Nausea) and FATIGUE (very tired) had not resolved and DYSPHAGIA (could not eat anything and was only able to swallow water), FEELING OF BODY TEMPERATURE CHANGE (freezing alternating with feeling very hot), PAIN IN EXTREMITY (most of my arm was red and painful to touch), ERYTHEMA (most of my arm was red and painful to touch) and MYALGIA (body ache) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Dec-2020, SARS-CoV-2 test: (Positive) She did not have a bad case and recovered from it..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment medications were reported.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pain in extremity, SARS-CoV-2 test
Clinical narrative: started feeling very ill/very sick; could not eat anything and was only able to swallow water; freezing alternating with feeling very hot; most of my arm was red and painful to touch; most of my arm was red and painful to touch; Nausea; body ache; very tired; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (started feeling very ill/very sick), DYSPHAGIA (could not eat anything and was only able to swallow water), FEELING OF BODY TEMPERATURE CHANGE (freezing alternating with feeling very hot), PAIN IN EXTREMITY (most of my arm was red and painful to touch) and ERYTHEMA (most of my arm was red and painful to touch) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced MALAISE (started feeling very ill/very sick), DYSPHAGIA (could not eat anything and was only able to swallow water), FEELING OF BODY TEMPERATURE CHANGE (freezing alternating with feeling very hot), PAIN IN EXTREMITY (most of my arm was red and painful to touch), ERYTHEMA (most of my arm was red and painful to touch), NAUSEA (Nausea), MYALGIA (body ache) and FATIGUE (very tired). At the time of the report, MALAISE (started feeling very ill/very sick), NAUSEA (Nausea) and FATIGUE (very tired) had not resolved and DYSPHAGIA (could not eat anything and was only able to swallow water), FEELING OF BODY TEMPERATURE CHANGE (freezing alternating with feeling very hot), PAIN IN EXTREMITY (most of my arm was red and painful to touch), ERYTHEMA (most of my arm was red and painful to touch) and MYALGIA (body ache) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Dec-2020, SARS-CoV-2 test: (Positive) She did not have a bad case and recovered from it..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Agitation, Anxiety, Irritability, Vaccination site pain
Clinical narrative: started to feel agitated,anxious, irritated; started to feel agitated,anxious, irritated; started to feel agitated,anxious, irritated; injection site was sore but it went away; This spontaneous case was reported by a consumer and describes the occurrence of AGITATION (started to feel agitated,anxious, irritated), ANXIETY (started to feel agitated,anxious, irritated), IRRITABILITY (started to feel agitated,anxious, irritated) and VACCINATION SITE PAIN (injection site was sore but it went away) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE PAIN (injection site was sore but it went away). On 15-Jan-2021, the patient experienced AGITATION (started to feel agitated,anxious, irritated), ANXIETY (started to feel agitated,anxious, irritated) and IRRITABILITY (started to feel agitated,anxious, irritated). At the time of the report, AGITATION (started to feel agitated,anxious, irritated), ANXIETY (started to feel agitated,anxious, irritated) and IRRITABILITY (started to feel agitated,anxious, irritated) outcome was unknown and VACCINATION SITE PAIN (injection site was sore but it went away) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment  medications were reported.    This case was linked to US-MODERNATX, INC.-MOD-2021-076594 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-076594:Case for Dose 1
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash macular, Swelling face
Clinical narrative: Face swelled up; Really pronounced red spots; Face swelled up with sores; This spontaneous case was reported by a non-health professional and describes the occurrence of SWELLING FACE (Face swelled up), RASH MACULAR (Really pronounced red spots) and RASH (Face swelled up with sores) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced SWELLING FACE (Face swelled up), RASH MACULAR (Really pronounced red spots) and RASH (Face swelled up with sores). At the time of the report, SWELLING FACE (Face swelled up), RASH MACULAR (Really pronounced red spots) and RASH (Face swelled up with sores) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product use was reported. No treatment medications were reported.